A fusion protein and application of an anti-c3d targeting single-chain antibody and daf
A single-chain antibody and fusion protein technology, applied in the field of peptides, can solve problems affecting the targeting effect of anti-C3d antibodies, increase protein molecular weight, etc., and achieve excellent anti-adhesion/anti-inflammatory targeting inhibition effect, vasculitis improvement, crescent moon Body/necrosis improvement effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Embodiment 1, preparation of anti-C3d single chain antibody
[0026] Use the following method to screen anti-C3d single-chain antibody, and the specific method includes the following steps:
[0027] 1.1 Preparation of cDNA
[0028]20 ml of peripheral blood from 50 healthy individuals were collected, and mononuclear cells were separated with lymphocyte separation medium (Tianjin Blood Research Institute). Total RNA was extracted from isolated human peripheral blood lymphocytes with Trizol reagent (Invitrogen), and then mixed in the same ratio. The cDNA was reverse transcribed using a cDNA reverse transcription kit (Takara Company). The above steps were carried out according to the instructions provided by the manufacturer.
[0029] 1.2 Amplification of antibody light chain and heavy chain variable region genes: Using PCR method, using the cDNA synthesized by reverse transcription as a template, add primers for amplifying the light chain and heavy chain variable region...
Embodiment 2
[0050] Example 2 Preparation of anti-C3d single-chain antibody-DAF (ScFv-DAF) fusion protein
[0051] 1. Materials The expression vector was pEE14.1 (Lonza biologicals); CHO cells were used for protein expression, and the culture medium was DMEM containing 10% fetal bovine serum, which was purchased from Invitrogen. Mouse anti-DAF mAb 1H4 and 1A10, mouse anti-human CR2 mAb 171, anti-goat erythrocyte IgM and all secondary antibodies were purchased from Sigma.
[0052] 2 methods
[0053] 2.1 The preparation of rabbit anti-CHO cell membrane and human DAF antiserum was described in Harlow, E., and Lane, D. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory. Cold Spring Harbor, New York, USA. 1988: 726. method to obtain.
[0054] 2.2 Construction of expression recombinant and protein expression The cDNA structural gene was formed by linking the sequence encoding the anti-C3d single-chain antibody and the sequence encoding the extracellular domain of DAF. The complement...
Embodiment 3
[0074] Example 3. Kinetic analysis of interaction between ScFv-DAF and C3 ligand
[0075] Kinetic analysis of the interaction of ScFv-DAF with biotin-labeled C3dg (C3dg-biotin) was performed using a surface plasmon resonance (SPR) detection system (BIAcore 3000 instrument). Human C3dg-biotin (Guthridge, J.M., et al. Structural studies in solution of the recombinant N-terminal pair of short consensus / complement repeat domains of complement receptor type 2 (CR2 / CD21) and interactions with its ligandC3dg.Biochemistry.2001,40(20):5931–5941.) were injected onto the BIAcore streptavidin sensor chip at a rate of 2μL / min for 20min, and the buffer was 0.5× PBS (pH7.4) (containing 0.5g / L Tween20). SPR signals acquired from captured C3dg yielded BIAcore response units (range 250 to 500). The group without fusion protein was used as the control. After washing with 0.5×PBST (0.5g / L Tween20) at 25°C at a flow rate of 25μL / min, the affinity of ScFv-DAF was evaluated by detecting the conc...
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com